Evaluating the safety and efficacy of axitinib in the treatment of advanced renal cell carcinoma.

Gunnarsson, Orvar; Pfanzelter, Nicklas R; Cohen, Roger B; Keefe, Stephen M

Gunnarsson, Orvar; Pfanzelter, Nicklas R; Cohen, Roger B; Keefe, Stephen M.

Affiliation

Gunnarsson O; Department of Medicine, Division of Hematology and Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
Pfanzelter NR; Department of Medicine, Division of Hematology and Oncology, Rush University Medical Center, Chicago, IL, USA.
Cohen RB; Department of Medicine, Division of Hematology and Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
Keefe SM; Department of Medicine, Division of Hematology and Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.

Cancer Manag Res ; 7: 65-73, 2015.

Article de En | MEDLINE | ID: mdl-25709499

Mots clés

axitinib; drug safety; renal cell carcinoma; side effects

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Clinical_trials Aspects: Patient_preference Langue: En Journal: Cancer Manag Res Année: 2015 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google